Details for New Drug Application (NDA): 065251
NDA 065251 describes CEFUROXIME SODIUM IN PLASTIC CONTAINER, which is a drug marketed by Samson Medcl and is included in one NDA. Additional details are available on the CEFUROXIME SODIUM IN PLASTIC CONTAINER profile page.
The generic ingredient in CEFUROXIME SODIUM IN PLASTIC CONTAINER is cefuroxime sodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
The generic ingredient in CEFUROXIME SODIUM IN PLASTIC CONTAINER is cefuroxime sodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
Summary for 065251
| Tradename: | CEFUROXIME SODIUM IN PLASTIC CONTAINER |
| Applicant: | Samson Medcl |
| Ingredient: | cefuroxime sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 75GM BASE/VIAL | ||||
| Approval Date: | Dec 30, 2009 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 225GM BASE/VIAL | ||||
| Approval Date: | Dec 30, 2009 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
